In a clinical trial in locally advanced or inoperable NSCLC patients treated with radiotherapy, sPD-L1 levels were measured showing that patients with lower baseline sPD-L1 levels had longer OS [54]. The gene discussed is SPDL1; the disease is non-small cell lung carcinoma.